Baseline characteristic | Predicted probability | Absolute change from reference | Relative change from reference | P value | |
DHP status | Non-DHP | 0.37 | |||
DHP | 0.29 | −0.08 | −0.21 | 0.001 | |
Gender | Female | 0.37 | |||
Male | 0.35 | −0.02 | −0.04 | 0.092 | |
Age | 19–34 | 0.30 | |||
35–44 | 0.33 | 0.03 | 0.13 | 0.325 | |
45–54 | 0.37 | 0.07 | 0.22 | 0.018 | |
55–62 | 0.38 | 0.08 | 0.25 | 0.002 | |
Baseline risk based on level of dysglycemia | Low A1c 5.7%–5.9% FPG 100–109 mg/dL | 0.29 | |||
High A1c 6%–6.4% FPG 110–125 mg/dL | 0.50 | 0.21 | 0.74 | <0.001 | |
ICD-9/OGTT | 0.34 | 0.05 | 0.16 | 0.454 | |
Baseline A1c/FPG/OGTT lab test count | 0 | 0.71 | |||
1 | 0.30 | −0.41 | −0.57 | <0.001 | |
2 | 0.28 | −0.43 | −0.60 | <0.001 | |
3+ | 0.32 | −0.39 | −0.55 | <0.001 | |
ICD-9 obesity | No | 0.35 | |||
Yes | 0.47 | 0.12 | 0.36 | <0.001 | |
Education | HS or less | 0.38 | |||
Some college | 0.35 | −0.03 | −0.07 | 0.117 | |
College degree | 0.33 | −0.05 | −0.14 | 0.019 | |
Income | <$30 000 | 0.41 | |||
$30 000–$49 000 | 0.38 | −0.03 | −0.06 | 0.325 | |
$50 000–$74 000 | 0.35 | −0.05 | −0.13 | 0.032 | |
$75 000+ | 0.34 | −0.06 | −0.15 | 0.016 | |
Race/ethnicity | White | 0.35 | |||
Hispanic | 0.37 | 0.02 | 0.05 | 0.127 | |
African–American | 0.35 | −0.01 | −0.02 | 0.649 | |
Asian | 0.38 | 0.02 | 0.06 | 0.388 | |
Other | 0.51 | 0.16 | 0.44 | 0.031 | |
Mental health comorbidity | No | 0.36 | |||
Yes | 0.37 | 0.02 | 0.05 | 0.293 |
Mental health comorbidity was defined by ≥1 ICD-9 related diagnosis for schizophrenia, depression, anxiety and/or post-traumatic stress disorder. Higher A1c/FPG at baseline=baseline A1c 6.0%–6.4% or FPG 110–125 mg/dL. Obese was defined by ≥1 ICD-9 related diagnosis of body mass index (BMI) ≥30 kg/m2.
Bold values denote statistical significance at the p<0.05 level
DHP, Diabetes Health Plan; FPG, fasting plasma glucose; HS, high school; ICD-9, International Classification of Diseases 9th Revision; OGTT, oral glucose tolerance test.